Contraindicated (1)pentobarbital will decrease the extent or outcome of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is responsible for the formation and elimination of cariprazine's active metabolites.pentobarbital will lessen the level or result of lonafarnib by affecting hepatic/intestinal enzyme